Johnson & Johnson beats talc lawsuit in California court case

By Lynsey Barber | Published: 8-Jun-2026
Ingredients Regulatory

A jury has reached a verdict in a lawsuit brought forward by three women, which alleged J&J’s talc products caused ovarian cancer

You need to be a subscriber to read this article.
Click here to find out more.

Johnson & Johnson (J&J) has beaten a US lawsuit related to claims over its talc products.

A lawsuit was brought by the families of three women – Mary Owens, ​Bonnie Tienken and Geneva Williams – who alleged that the company's talc products caused ovarian ​cancer.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Regulatory

Neutrogena owner agrees $4.7 million settlement over Skin360 biometric data privacy claims

Read more
Johnson & Johnson Consumer, which is now known as Kenvue, has agreed to a settlement in a class action lawsuit, in which it was alleged that the skin care brand’s facial scanning technology collected and stored data without users’ consent

Trending Articles

  1. L’Oréal faces six lawsuits over benzene contamination in acne treatments The US Judicial Panel on Multidistrict Litigation will begin hearings on the lawsuits at the end of the month
  2. Revolution Beauty investigation closed by UK financial watchdog Three years after launching a probe into cosmetics company Revolution Beauty, the UK’s Financial Conduct Authority is taking no further action
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Move over, mascara – Tarte Cosmetics just launched a tubing eyeliner The latest launch from Tarte Cosmetics sees the make-up brand’s mascara tubing technology applied to a liquid eyeliner. Founder and CEO Maureen Kelly tells Cosmetics Business all about the launch
  4. MSL Solution Providers celebrates 25 years of scientific and regulatory excellence 2026 marks 25 years of MSL Solution Providers, one of the UK’s leading microbiological testing and regulatory houses for cosmetics, personal care and household cleansing products

Upcoming event

Anti-Ageing Skin Care Conference

23-24 June 2026 | London, UK See all

You may also like

Regulatory

Neutrogena owner agrees $4.7 million settlement over Skin360 biometric data privacy claims

Johnson & Johnson Consumer, which is now known as Kenvue, has agreed to a settlement in a class action lawsuit, in which it was alleged that the skin care brand’s facial scanning technology collected and stored data without users’ consent
Regulatory

J&J faces biometric privacy lawsuit in US over Neutrogena Skin360 facial-scanning service

The healthcare giant failed to convince a federal judge that the facial-scanning service falls under an Illinois law’s healthcare exemption
Regulatory

New J&J talc lawsuit first to seek medical monitoring for cancer

The proposed class action is the first to seek medical monitoring, or regular testing for female talc users to catch cancer early
Regulatory

Johnson & Johnson to appeal $19 million owed to California cancer patient

The talc cancer trial involving 24-year-old Emory Hernandez Valadez was the first faced by J&J since its bankruptcy filing
Regulatory

Johnson & Johnson faces first new talc cancer trial since bankruptcy filing

Judge overseeing LTL Management’s Chapter 11 has allowed the trial to go ahead, as 24-year-old cancer patient Anthony Hernandez Valadez does not have long to live
Regulatory

US judge pauses J&J talc trials, but healthcare giant may face new suits

The 60-day freeze advances J&J’s second attempt to settle cases through subsidiary LTL Management’s bankruptcy proceedings
Regulatory

J&J's first quarter earnings plummet following $6.9 billion talc litigation charge

J&J originally proposed a $8.9bn settlement to resolve its ongoing talc litigation woes, and its subsidiary LTL Management has refiled for Chapter 11 bankruptcy
Subscribe now